Relief Therapeutics Holding AG (RLF) — Capital Reinvestment Ratio
Latest as of December 2024:
0.04x
Relief Therapeutics Holding AG (RLF) has a Capital Reinvestment Ratio of 0.04x as of December 2024, meaning it reinvests 0% of its operating cash flow (CHF359.00K) in capital expenditures (CHF14.00K). See Relief Therapeutics Holding AG free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
CHF359.00K
CHF
Capital Expenditures
CHF14.00K
CHF
Data as of
Dec 2024
Most recent filing
Relief Therapeutics Holding AG Capital Reinvestment Ratio (2006–2006)
This chart tracks Relief Therapeutics Holding AG's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Relief Therapeutics Holding AG (2006–2006)
Year-by-year Capital Reinvestment Ratio for Relief Therapeutics Holding AG from 2006 to 2006. For live market cap and broader valuation context, see RLF company net worth.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2006 | 0.21x | CHF2.28 Million | CHF474.60K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow